Prof Chuen Yan Cheng | |
---|---|
Born | |
Nationality | American |
Alma mater |
Chinese University of Hong Kong (B.Sc.)
University of Newcastle, Australia (Ph.D.) |
Known for | Male contraceptive drug |
Awards | Richard E. Weizman Memorial Award Best Scientific Paper Award |
Scientific career | |
Fields | Biochemistry |
Institutions | Rockefeller University |
Chuen Yan Cheng ( Chinese: 鄭泉恩) is a Senior Scientist for the Population Council's Center for Biomedical Research. He is most well known as the inventor of the non- steroid male contraceptive drug—— Adjudin, [1] [2] [3] [4] which is the first male contraceptive drug on the market now finished clinical trials showing no side effects. [5] [6]
He graduated from the Chinese University of Hong Kong with a B.Sc. in 1977, and obtained his Ph.D. in biochemistry and cell biology at the University of Newcastle, Australia, in 1981. He came to New York as a Population Council post-doctoral trainee in 1981, studying in the laboratory of Drs. Wayne Bardin, Neal Musto, and Glen Gunsalus and was appointed as a research investigator in December 1982.
Cheng's research focuses on the development of a novel contraceptive for human males. These studies currently are supported by grants from the National Institutes of Health, the CONRAD Program, and the Andrew Mellon Foundation.
{{
cite web}}
: CS1 maint: unfit URL (
link)
Prof Chuen Yan Cheng | |
---|---|
Born | |
Nationality | American |
Alma mater |
Chinese University of Hong Kong (B.Sc.)
University of Newcastle, Australia (Ph.D.) |
Known for | Male contraceptive drug |
Awards | Richard E. Weizman Memorial Award Best Scientific Paper Award |
Scientific career | |
Fields | Biochemistry |
Institutions | Rockefeller University |
Chuen Yan Cheng ( Chinese: 鄭泉恩) is a Senior Scientist for the Population Council's Center for Biomedical Research. He is most well known as the inventor of the non- steroid male contraceptive drug—— Adjudin, [1] [2] [3] [4] which is the first male contraceptive drug on the market now finished clinical trials showing no side effects. [5] [6]
He graduated from the Chinese University of Hong Kong with a B.Sc. in 1977, and obtained his Ph.D. in biochemistry and cell biology at the University of Newcastle, Australia, in 1981. He came to New York as a Population Council post-doctoral trainee in 1981, studying in the laboratory of Drs. Wayne Bardin, Neal Musto, and Glen Gunsalus and was appointed as a research investigator in December 1982.
Cheng's research focuses on the development of a novel contraceptive for human males. These studies currently are supported by grants from the National Institutes of Health, the CONRAD Program, and the Andrew Mellon Foundation.
{{
cite web}}
: CS1 maint: unfit URL (
link)